126 Results for "

fms

" in MedChemExpress (MCE) Product Catalog:
Products (126)

126 Results for "fms" in MCE Product Catalog:

42
42 Publications Verification
Cat. No.: HY-12768
CAS No.: 953769-46-5
Purity:  99.83%
Synonyms: BLZ945
Target:  

c-Fms

Research Areas:  

Infection Neurological Disease Cancer

Sotuletinib (BLZ945) is a potent, selective, orally active and brain-penetrant CSF-1R (c-Fms) inhibitor with an IC50 of 1 nM, showing more than 1,000-fold selectivity against its closest receptor tyrosine kinase homologs. Sotuletinib can be used for microglia depletion, and for tumor and CNS-related disease research .
loading...
    loading...
42
42 Publications Verification
Cat. No.: HY-12768A
CAS No.: 2222138-31-8
Purity:  99.43%
Synonyms: BLZ945 hydrochloride
Target:  

c-Fms

Research Areas:  

Cancer

Sotuletinib (BLZ945) hydrochloride is a potent, selective, orally active and brain-penetrant CSF-1R (c-Fms) inhibitor with an IC50 of 1 nM, showing more than 1,000-fold selectivity against its closest receptor tyrosine kinase homologs. Sotuletinib hydrochloride can be used for microglia depletion, and for tumor and CNS-related disease research. .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-10208
CAS No.: 444731-52-6
Purity:  99.91%
Synonyms: GW786034
Research Areas:  

Cancer

Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-12009
CAS No.: 635702-64-6
Purity:  99.99%
Synonyms: GW786034 Hydrochloride
Research Areas:  

Cancer

Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-10917
CAS No.: 870483-87-7
Purity:  99.90%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

GW2580 is an orally bioavailable and selective inhibitor of c-Fms kinase which completely inhibits human cFMS kinase in vitro at 0.06 μM. GW2580 acts as a competitive inhibitor of ATP binding to the cFMS kinase and inhibits colony-stimulating-factor-1 signaling .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-10542
CAS No.: 220904-83-6
Purity:  99.49%
Target:  

Raf Apoptosis

Research Areas:  

Cancer

GW 5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, and has no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10032
CAS No.: 952021-60-2
Purity:  99.21%
Synonyms: PF 00477736
PF 477736 (PF 00477736) is a potent, selective and ATP-competitive inhibitor of Chk1, with a Ki of 0.49 nM, it is also a Chk2 inhibitor, with a Ki of 47 nM. PF 477736 shows <100-fold selectivity for Chk1 over VEGFR2, Fms, Yes, Aurora-A, FGFR3, Flt3, and Ret (IC50=8 (Ki), 10, 14, 23, 23, 25, and 39 nM, respectively). PF 477736 can enhance Gemcitabine antitumor activity in vitro and in vivo .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10408
CAS No.: 623142-96-1
Purity:  99.51%
Target:  

c-Fms VEGFR c-Kit PDGFR

Research Areas:  

Inflammation/Immunology

Ki20227 is an orally active and highly selective c-Fms tyrosine kinase (CSF1R) inhibitor with IC50s of 2 nM, 12 nM, 451 and 217 nM for CSF1R, VEGFR2 (vascular endothelial growth factor receptor-2), c-Kit (stem cell factor receptor) and PDGFRβ (platelet-derived growth factor receptor β). Ki20227 suppresses osteoclast differentiation and osteolytic bone destruction .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10204
CAS No.: 728033-96-3
Purity:  98.57%
Target:  

c-Kit VEGFR c-Fms Apoptosis

Research Areas:  

Cancer

OSI-930 is an orally selective inhibitor of Kit, KDR and CSF-1R (c-Fms) with IC50s of 80 nM, 9 nM and 15 nM, respectively. OSI-930 also moderately inhibits Flt-1, c-Raf, Lck and low activity against PDGFRα/β, Flt-3 and Abl. OSI-930 has antitumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P70178
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuReceptor-Type Tyrosine-Protein Kinase FLT3/FLT3, Fc; Receptor-Type Tyrosine-Protein Kinase FLT3; FL Cytokine Receptor; Fetal Liver Kinase-2; FLK-2; fms-Like Tyrosine Kinase 3; FLT-3; Stem Cell Tyrosine Kinase 1; STK-1; CD135; FLT3; FLK2; STK1
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70563
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: fms-related tyrosine kinase 3 ligand (Flt3L); SL cytokine; Flt3 ligand
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P72948
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Macrophage colony-stimulating factor 1 receptor; CSF-1R; M-CSF-R; CD115; CSF1R; fms
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-136256
CAS No.: 1628606-05-2
Purity:  99.94%
Synonyms: DCC-3014
Target:  

c-Fms c-Kit

Research Areas:  

Cancer

Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively . Vimseltinib has certain oral bioavailability .
loading...
    loading...
Cat. No.: HY-111787
CAS No.: 2271119-26-5
Purity:  99.93%
Synonyms: TPX-0022; CSF1R-IN-2
Target:  

Src c-Met/HGFR c-Fms

Research Areas:  

Cancer

Elzovantinib (TPX-0022) is an oral-active inhibitor of SRC, MET and c-FMS, with IC50 values of 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively .
loading...
    loading...
Cat. No.: HY-100867A
CAS No.: 1952251-28-3
Purity:  99.86%
Synonyms: TAK-659 monohydrochloride; CB-659 monohydrochloride
Target:  

Syk FLT3

Research Areas:  

Cancer

TAK-659 hydrochloride is a highly potent, selective, reversible and orally available dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), with an IC50 of 3.2 nM and 4.6 nM for SYK and FLT3, respectively. TAK-659 hydrochloride induces cell death in tumor cells but not in nontumor cells, and with potential for the treatment of chronic lymphocytic leukemia (CLL) .
loading...
    loading...
Cat. No.: HY-13838
CAS No.: 873786-09-5
Purity:  99.74%
Target:  

c-Fms c-Kit

Research Areas:  

Cancer

PLX647 is an orally active, highly specific dual FMS and KIT kinase inhibitor, with IC50s of 28 and 16 nM, respectively. PLX647 shows selectivity for FMS and KIT over a panel of 400 kinases at a concentration of 1 μM except FLT3 and KDR (IC50s=91 and 130 nM, respectively) .
loading...
    loading...
Cat. No.: HY-126297
CAS No.: 1527517-50-5
Purity:  98.63%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

c-Fms-IN-10 is the derivative of thieno [3,2-d] pyrimidine, an kinase inhibitor of FMS (Colony stimulating factor-1 receptor, CSF-1R) with IC50 of 2 nM. c-Fms-IN-10 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-136362
CAS No.: 1313407-95-2
Purity:  99.63%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers .
loading...
    loading...
Cat. No.: HY-108263
CAS No.: 179237-49-1
Purity:  97.02%
Synonyms: CGP52421
Target:  

FLT3

Research Areas:  

Cancer

3-Hydroxy Midostaurin (CGP 52421), a metabolite of PKC412, effectively inhibits FMS-like tyrosine kinase-3 (FLT3) autophosphorylation with IC50s of approximately 132 nM and 9.8 μM in culture medium and plasma, respectively. 3-Hydroxy Midostaurin is less selective but more cytotoxic than PKC412 .
loading...
    loading...
Cat. No.: HY-18791
CAS No.: 885703-64-0
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology

c-Fms-IN-1 is a FMS kinase inhibitor with an IC50 of 0.0008 μM .
loading...
    loading...